Phase I, Single Centre, Open Label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous AZD3043 After a Single Ascending Bolus Dose Followed by a Single Infusion Dose in Elderly (=65 Years) Healthy Volunteers.
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 19 Dec 2012
At a glance
- Drugs AZD 3043 (Primary)
- Indications Perioperative pain
- Focus Adverse reactions
- 19 Dec 2012 Last checked against ClinicalTrials.gov record
- 15 Feb 2011 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 18 Mar 2010 New trial record